Voltar
Artigo Revisado por pares
BIBTEX RIS

A phase I open-label study of the safety, tolerability, and pharmacokinetics of pazopanib in combination with irinotecan and cetuximab for relapsed or refractory metastatic colorectal cancer

2014; Springer Science+Business Media; Volume: 33; Issue: 1 Linguagem: Inglês

10.1007/s10637-014-0142-1

ISSN

1573-0646

Autores

Jaafar Bennouna, Marion Deslandres, Hélène Senellart, Cécile de Labareyre, Rodrigo Ruiz-Soto, Claire Wixon, Jeff Botbyl, A. Benjamin Suttle, Jean‐Pierre Delord,

Tópico(s)

Cancer Treatment and Pharmacology

Referência(s)